Skip to content
Screener

Lexeo Therapeutics, Inc. LXEO Q1 2026 earnings

Reported May 11, 2026 · Before market open

EPS-$0.25Beat by $0.04
EPS estimate-$0.29

Next report

Dec 14, 2026 (in 3 months)
EPS estimate-$0.33

FAQ

When did Lexeo Therapeutics, Inc. report Q1 2026 earnings?
Lexeo Therapeutics, Inc. (LXEO) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Lexeo Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Lexeo Therapeutics, Inc. reported eps of $-0.25 for Q1 2026.
Did Lexeo Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.29 by $0.04.
How did Lexeo Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 74.7% from $-0.99.
Where can I find Lexeo Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-215674) and the 10-Q periodic report (0001193125-26-215678) directly on SEC EDGAR. The filing index links above go to sec.gov.